CSIMarket


Quest Diagnostics Inc  (DGX)
Other Ticker:  
 
    Sector  Healthcare    Industry Medical Laboratories
   Industry Medical Laboratories
   Sector  Healthcare


 

Quest Diagnostics Inc

DGX's Financial Statements and Analysis



Quest Diagnostics Inc reported in the forth quarter of 2023 net earnings per share of $1.68 an increase by 91.92 % year on year from $0.88 and decline of -14.12 % from $1.96 earned in III. Quarter (Sep 30 2023).


forth quarter of 2023
Earnings Per Share Revenues
$ 1.68 $  2,288 Mill
$+0.80     +91.92 % $-45M     -1.93 %



Quest Diagnostics Inc's Revenue fell by -1.93 % in forth quarter of 2023 (Dec 31 2023) year on year, to $2,288 million and declined by -0.31 % sequentially.


Quest Diagnostics Inc is

More on DGX's Income Statement



Quest Diagnostics Inc's net income of $205.000 million in the forth quarter of 2023 increased by 76.72 % from net earnings of $116.000 million achieved in IV. Quarter a year ago.

Sequentially net earnings fell by -13.5 % from net income of $237.000 million realized in previous quarter.

More on DGX's Growth




Quest Diagnostics Inc Inventories
Inventories declined by -1.04 % to $190.00 million from IV. Quarter a year ago, sequentially inventories rose by 3.26 %. DGX's Cash flow In the forth quarter of 2023 company's net cash flow was $543 million, capital expenditures grew by -147-51.02%, to $-72 millions compare to same quarter a year ago

More on DGX's Cash flow Statement


Quest Diagnostics Inc payed out dividend of $2.76 per share in last 52 weeks representing 36.95 % of net earning per share in trailing twelve-month period.

During the same period Quest Diagnostics Inc earned $ 11.16 cash per share, on a free-cash flow basis 149.34 % of net earning per share.

Book value fell by -1.89 % sequentially to $55.62 per share.
Tangible Book value fell to $ -22.43 per share from $ -21.82.

Company issued 0.02 million shares or 0.02 % in Dec 31 2023.
Interest Coverage Ratio was 8.43. Debt Coverage Ratio was 0.3.

More on DGX's Dividends

 Market Capitalization (Millions) 15,177
 Shares Outstanding (Millions) 114
 Total Debt (Millions $) 4,713
 Revenue (TTM) (Millions $) 9,252
 Net Income (TTM) (Millions $) 908
 Cash Flow (TTM) (Millions $) 371
 Capital Exp. (TTM) (Millions $) -408
 Dividend TTM ($) 2.76 $
 Dividend Yield TTM (%) 2.11 %
 Employees (TTM) $ 49,000




Quest Diagnostics Inc payed out dividend of $2.76 per share in the last 52 weeks representing 36.95 % of net earning per share in trailing twelve-month period.

During the same period Quest Diagnostics Inc had $ 11.16 cash flow per share, on a free-cash flow basis 149.34 % of net earning per share.

Book value fell by -1.89 % sequentially to $55.62 per share.
Tangible Book value fell to $ -22.43 per share from $ -21.82.

Company issued 0.02 million shares or 0.02 % in Dec 31 2023.
Interest Coverage Ratio was 8.43. Debt Coverage Ratio was 0.3.

More on DGX's Balance Sheets

 Market Capitalization (Millions) 15,177
 Shares Outstanding (Millions) 114
 Total Debt (Millions $) 4,713
 Revenue (TTM) (Millions $) 9,252
 Net Income (TTM) (Millions $) 908
 Cash Flow (TTM) (Millions $) 371
 Capital Exp. (TTM) (Millions $) -408
 Dividend TTM ($) 2.76 $
 Dividend Yield TTM (%) 2.11 %
 Employees (TTM) $ 49,000
   


  News about Quest Diagnostics Inc Earnings

Quest Diagnostics Inc defies expectations with a surge in earnings per share despite a decline in revenue

In the financial fourth quarter of 2023, Quest Diagnostics Inc (DGX) reported a decrease in revenue but managed to raise its earnings per share, showing positive growth in its income per share. Despite a decline in revenue by -1.929% to $2.29 billion year on year, income per share surged by 91.92% to $1.68 per share. This marks a decrease from the previous reporting period where profits fell from $1.96 per share and revenue decreased by -0.305% from $2.30 billion.
Net income also saw a significant increase in the financial fourth quarter of 2023, rising by 76.72% to $205.000 million from $116.000 million reported in the same quarter a year ago. Quest Diagnostics Inc also highlighted its improving profit ...

Quest Diagnostics Inc. Reports Decline in Financial Performance for Fiscal Q3 2023

Quest Diagnostics Inc, one of the leading medical laboratories in the industry, reported a decline in its bottom-line and income per share for the July to September 30, 2023 interval. The bottom-line decreased by 9.68% to $1.96 per share compared to $2.17 per share in the same period a year ago, while income per share decreased by 4.39% from $2.05 per share in the previous reporting period.
These disappointing results were mirrored in the company's revenue, which decreased by 7.683% to $2.30 billion from $2.49 billion in the comparable reporting period last year. Sequentially, the revenue declined by 1.839% from $2.34 billion. It is important to note that this deterioration in revenue is in stark contra...

Quest Diagnostics Masks Revenue Dip with Impressive Earnings: Sees Minor Decline but Delivers 4.59% EPS Growth as Industry Thrives

Quest Diagnostics Inc, a leading provider of diagnostic testing services, recently released its financial results for the fiscal second quarter of 2023. Despite facing soft demand during this period, the company managed to improve its earnings per share (EPS) by 4.59% to $2.05 per share. However, revenue experienced a decline of -4.688% to $2.34 billion compared to the same period last year.
In contrast to Quest Diagnostics Inc, the rest of the Medical Laboratories industry recorded a revenue improvement during the second quarter of 2023. Looking at the results from the previous reporting period, revenue surged by 0.3% from $2.33 billion, and EPSS increased by 15.17% from $1.78 per share. Unfortunately, ...

Serious revenue drop, at the company in the financial three months ending March 31 2023

Quest Diagnostics Inc. is a leading diagnostic testing and information services company with a reputation for delivering high-quality services to patients, physicians, hospitals, and other diagnostic providers. The company offers a broad range of diagnostic testing services, including routine and specialty testing, clinical and anatomic pathology, and toxicology testing. As one of the largest clinical laboratories in the United States, Quest Diagnostics Inc. serves millions of patients every year through its extensive network of more than 2,200 patient service centers and over 220 logistics locations throughout the country.
Recent Financial Performance
In the first quarter of 2023, Quest Diagnostics ...


Date modified: 2024-02-23T13:25:08+00:00





Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com